Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, AIM ImmunoTech Inc (AMEX: AIM) closed at $1.13 down -10.32% from its previous closing price of $1.26. In other words, the price has decreased by -$10.32 from its previous closing price. On the day, 0.47 million shares were traded. AIM stock price reached its highest trading level at $1.2198 during the session, while it also had its lowest trading level at $1.07.
Ratios:
For a deeper understanding of AIM ImmunoTech Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.64 and its Current Ratio is at 0.64.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 04 ’25 when Equels Thomas K bought 41,000 shares for $0.06 per share. The transaction valued at 2,583 led to the insider holds 1,899,029 shares of the business.
Rodino Peter W III bought 500 shares of AIM for $44 on Apr 04 ’25. The COO, Secretary, Gen. Counsel now owns 401,762 shares after completing the transaction at $0.09 per share. On Mar 05 ’25, another insider, Equels Thomas K, who serves as the CEO & President of the company, bought 50,000 shares for $0.13 each. As a result, the insider paid 6,730 and bolstered with 1,858,029 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AIM now has a Market Capitalization of 3320709 and an Enterprise Value of 3153018. For the stock, the TTM Price-to-Sale (P/S) ratio is 30.17. Its current Enterprise Value per Revenue stands at 28.152 whereas that against EBITDA is -0.22.
Stock Price History:
The Beta on a monthly basis for AIM is 1.20, which has changed by -0.94272727 over the last 52 weeks, in comparison to a change of 0.17511821 over the same period for the S&P500. Over the past 52 weeks, AIM has reached a high of $36.00, while it has fallen to a 52-week low of $1.21. The 50-Day Moving Average of the stock is -30.83%, while the 200-Day Moving Average is calculated to be -77.56%.
Shares Statistics:
For the past three months, AIM has traded an average of 99.18K shares per day and 220270 over the past ten days. A total of 2.94M shares are outstanding, with a floating share count of 2.82M. Insiders hold about 4.06% of the company’s shares, while institutions hold 3.65% stake in the company. Shares short for AIM as of 1765756800 were 27032 with a Short Ratio of 0.27, compared to 1763078400 on 6913. Therefore, it implies a Short% of Shares Outstanding of 27032 and a Short% of Float of 0.95.
Earnings Estimates
Its stock is currently analyzed by 1.0 different market analysts. The consensus estimate for the next quarter is -$1.08, with high estimates of -$1.08 and low estimates of -$1.08. Analysts are recommending an EPS of between -$7.75 and -$7.75 for the fiscal current year, implying an average EPS of -$7.75. EPS for the following year is -$4.33, with 1.0 analysts recommending between -$4.33 and -$4.33.
Revenue Estimates
A total of 1 analysts have provided revenue estimates for AIM’s current fiscal year. The highest revenue estimate was $100k, while the lowest revenue estimate was $100k, resulting in an average revenue estimate of $100k. In the same quarter a year ago, actual revenue was $170k
